Cholangiocarcinoma Awareness Month With Kannan Thanikachalam, MD

Cholangiocarcinoma has historically been a challenging malignancy to treat, marked by limited therapeutic options and poor outcomes. In this interview honoring Cholangiocarcinoma Awareness Month, Kannan Thanikachalam, MD, a Gastrointestinal Medical Oncologist at Roswell Park Comprehensive Cancer Center, discusses how the treatment landscape has evolved in recent years and highlights the growing roles of immunotherapy, molecular profiling, and clinical trial participation in improving patient care.